CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities of 1.14 million shares for the 12-month period ending 2015-12-26, per its 10-K filed 2016-02-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities · last filed 2016-02-12
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2013-09-28 was 0.00 shares.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2013-06-29 was 0.00 shares.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2013-03-30 was 0.00 shares.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2012-09-29 was 0.00 shares.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2015 was 1.14M shares, a 22.23% increase from fiscal 2014.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2014 was 931.00K shares, a 24.30% increase from fiscal 2013.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2013 was 749.00K shares, a 51.56% increase from fiscal 2012.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2012 was 494.19K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 3 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 6 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 9 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 12 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 12 month as first filed |
|---|---|---|---|---|---|
| 2015-12-26 | 1.14M shares 10-K · filed 2016-02-12 | ||||
| 2014-12-27 | 931.00K shares 10-K · filed 2016-02-12 | ||||
| 2013-12-28 | 749.00K shares 10-K · filed 2016-02-12 | ||||
| 2013-09-28 | 0.00 shares 10-Q · filed 2013-10-30 | 0.00 shares 10-Q · filed 2013-10-30 | |||
| 2013-06-29 | 0.00 shares 10-Q · filed 2013-07-31 | 0.00 shares 10-Q · filed 2013-07-31 | |||
| 2013-03-30 | 0.00 shares 10-Q · filed 2013-05-08 | ||||
| 2012-12-29 | 494.19K shares 10-K · filed 2015-02-17 | 0.00 shares 10-K · filed 2013-02-27 | |||
| 2012-09-29 | 0.00 shares 10-Q · filed 2013-10-30 | 0.00 shares 10-Q · filed 2013-10-30 | |||
| 2012-06-30 | 0.00 shares 10-Q · filed 2013-07-31 | 0.00 shares 10-Q · filed 2013-07-31 | |||
| 2012-03-31 | 0.00 shares 10-Q · filed 2013-05-08 | ||||
| 2011-12-31 | 0.00 shares 10-K · filed 2013-02-27 | ||||
| 2011-09-24 | 0.00 shares 10-Q · filed 2012-11-01 | 0.00 shares 10-Q · filed 2012-11-01 | |||
| 2011-06-25 | 0.00 shares 10-Q · filed 2012-08-07 | 0.00 shares 10-Q · filed 2012-08-07 | |||
| 2011-03-26 | 0.00 shares 10-Q · filed 2012-05-04 | ||||
| 2010-12-25 | 0.00 shares 10-K · filed 2013-02-27 | ||||
| 2009-12-26 | 0.00 shares 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |